Active	Status	Sponsor type	Region	Phase	Filter
1 Active 19 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
vadimezan (ASA404) / Antisoma
2009-016834-28: An open-label, multi-center, continued access trial of investigational drug ASA404 for patients in previous ASA404 clinical trials	Ongoing	4		Europe	ASA404, ASA404,	Novartis Pharma Services AG	Solid tumors